@article{PimentelElardoBubackGulderetal.2011,
  author    = {Pimentel-Elardo, Sheila M. and Buback, Verena and Gulder, Tobias A. M. and Bugni, Tim S. and Reppart, Jason and Bringmann, Gerhard and Ireland, Chris M. and Schirmeister, Tanja and Hentschel, Ute},
  title     = {New Tetromycin Derivatives with Anti-Trypanosomal and Protease Inhibitory Activities},
  series = {Marine drugs},
  volume    = {9},
  journal   = {Marine drugs},
  number    = {10},
  doi       = {10.3390/md9101682},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-141171},
  pages     = {1682-1697},
  year      = {2011},
  abstract  = {Four new tetromycin derivatives, tetromycins 1-4 and a previously known one, tetromycin B (5) were isolated from Streptomyces axinellae Pol001(T) cultivated from the Mediterranean sponge Axinella polypoides. Structures were assigned using extensive 1D and 2D NMR spectroscopy as well as HRESIMS analysis. The compounds were tested for antiparasitic activities against Leishmania major and Trypanosoma brucei, and for protease inhibition against several cysteine proteases such as falcipain, rhodesain, cathepsin L, cathepsin B, and viral proteases SARS-CoV M(pro), and PL(pro). The compounds showed antiparasitic activities against T. brucei and time-dependent inhibition of cathepsin L-like proteases with K(i) values in the low micromolar range.},
  language  = {en}
}
@article{PimentelElardoBubackGulderetal.2011,
  author    = {Pimentel-Elardo, Sheila M. and Buback, Verena and Gulder, Tobias A. M. and Bugni, Tim S. and Reppart, Jason and Bringmann, Gerhard and Ireland, Chris M. and Schirmeister, Tanja and Hentschel, Ute},
  title     = {New Tetromycin Derivatives with Anti-Trypanosomal and Protease Inhibitory Activities},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-75465},
  year      = {2011},
  abstract  = {Four new tetromycin derivatives, tetromycins 1-4 and a previously known one, tetromycin B (5) were isolated from Streptomyces axinellae Pol001T cultivated from the Mediterranean sponge Axinella polypoides. Structures were assigned using extensive 1D and 2D NMR spectroscopy as well as HRESIMS analysis. The compounds were tested for antiparasitic activities against Leishmania major and Trypanosoma brucei, and for protease inhibition against several cysteine proteases such as falcipain, rhodesain, cathepsin L, cathepsin B, and viral proteases SARS-CoV Mpro, and PLpro. The compounds showed antiparasitic activities against T. brucei and time-dependent inhibition of cathepsin L-like proteases with Ki values in the low micromolar range.},
  subject      = {Biologie},
  language  = {en}
}
@article{AbdelmohsenPimentelElardoHanoraetal.2010,
  author    = {Abdelmohsen, Usama Ramadan and Pimentel-Elardo, Sheila M. and Hanora, Amro and Radwan, Mona and Abou-El-Ela, Soad H. and Ahmed, Safwat and Hentschel, Ute},
  title     = {Isolation, Phylogenetic Analysis and Anti-infective Activity Screening of Marine Sponge-Associated Actinomycetes},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-68307},
  year      = {2010},
  abstract  = {Terrestrial actinomycetes are noteworthy producers of a multitude of antibiotics, however the marine representatives are much less studied in this regard. In this study, 90 actinomycetes were isolated from 11 different species of marine sponges that had been collected from offshore Ras Mohamed (Egypt) and from Rovinj (Croatia). Phylogenetic characterization of the isolates based on 16S rRNA gene sequencing supported their assignment to 18 different actinomycete genera representing seven different suborders. Fourteen putatively novel species were identified based on sequence similarity values below 98.2\% to other strains in the NCBI database. A putative new genus related to Rubrobacter was isolated on M1 agar that had been amended with sponge extract, thus highlighting the need for innovative cultivation protocols. Testing for anti-infective activities was performed against clinically relevant, Gram-positive (Enterococcus faecalis, Staphylococcus aureus) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria, fungi (Candida albicans) and human parasites (Leishmania major, Trypanosoma brucei). Bioactivities against these pathogens were documented for 10 actinomycete isolates. These results show a high diversity of actinomycetes associated with marine sponges as well as highlight their potential to produce anti-infective agents.},
  subject      = {Biologie},
  language  = {en}
}
@article{PimentelElardoKozytskaBugnietal.2010,
  author    = {Pimentel-Elardo, Sheila Marie and Kozytska, Svitlana and Bugni, Tim S. and Ireland, Chris M. and Moll, Heidrun and Hentschel, Ute},
  title     = {Anti-Parasitic Compounds from Streptomyces sp. Strains Isolated from Mediterranean Sponges},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-68312},
  year      = {2010},
  abstract  = {Actinomycetes are prolific producers of pharmacologically important compounds accounting for about 70\% of the naturally derived antibiotics that are currently in clinical use. In this study, we report on the isolation of Streptomyces sp. strains from Mediterranean sponges, on their secondary metabolite production and on their screening for anti-infective activities. Bioassay-guided isolation and purification yielded three previously known compounds namely, cyclic depsipeptide valinomycin, indolocarbazole alkaloid staurosporine and butenolide. This is the first report of the isolation of valinomycin from a marine source. These compounds exhibited novel anti-parasitic activities specifically against Leishmania major (valinomycin IC50 < 0.11 μM; staurosporine IC50 5.30 μM) and Trypanosoma brucei brucei (valinomycin IC50 0.0032 μM; staurosporine IC50 0.022 μM; butenolide IC50 31.77 μM). These results underscore the potential of marine actinomycetes to produce bioactive compounds as well as the re-evaluation of previously known compounds for novel anti-infective activities.},
  subject      = {Biologie},
  language  = {en}
}
@article{ElHossaryAbdelHalimIbrahimetal.2020,
  author    = {El-Hossary, Ebaa M. and Abdel-Halim, Mohammad and Ibrahim, Eslam S. and Pimentel-Elardo, Sheila Marie and Nodwell, Justin R. and Handoussa, Heba and Abdelwahab, Miada F. and Holzgrabe, Ulrike and Abdelmohsen, Usama Ramadan},
  title     = {Natural Products Repertoire of the Red Sea},
  series = {Marine Drugs},
  volume    = {18},
  journal   = {Marine Drugs},
  number    = {9},
  issn      = {1660-3397},
  doi       = {10.3390/md18090457},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-213110},
  year      = {2020},
  abstract  = {Marine natural products have achieved great success as an important source of new lead compounds for drug discovery. The Red Sea provides enormous diversity on the biological scale in all domains of life including micro- and macro-organisms. In this review, which covers the literature to the end of 2019, we summarize the diversity of bioactive secondary metabolites derived from Red Sea micro- and macro-organisms, and discuss their biological potential whenever applicable. Moreover, the diversity of the Red Sea organisms is highlighted as well as their genomic potential. This review is a comprehensive study that compares the natural products recovered from the Red Sea in terms of ecological role and pharmacological activities.},
  language  = {en}
}